Fierce Pharma covers the pharma waterfront, from late-stage drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, ...
13.12.2021 · Korro Bio rings in new year with $116M for OPERA RNA editing. Ticket sales for Korro Bio's second financing round landed at $116 million as the biotech builds up funds to bankroll its RNA editing ...
10.01.2022 · Fierce Pharma will be covering the day's biggest news at it happens. Check back here for updates, and catch Fierce Biotech's coverage here . …
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products ...
News, insights and education shaped by experts in pharma and biotech. Fierce Life Sciences offers a full suite of ... Visit Fierce Pharma. Fierce-Biotech.
FiercePharma The Pharma Industry Daily Monitor Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Pharma as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D.
Read the latest biotechnology articles on biotech industry leaders, emerging biotech companies, FDA decisions, VC deals, and other biotech industry news.
news, the recap of. @JNJNews. new CEO Juaquin Duato's conversation and more. fiercepharma.com. #JPM22, Day 1: Bristol Myers Squibb's blockbuster losses of ...
Jan 04, 2022 · Visit FiercePharma for pharma industry news on big pharma, FDA decisions, patents, pharmaceutical marketing, generic drugs, and other pharma news.
Dec 13, 2021 · Korro Bio rings in new year with $116M for OPERA RNA editing. Ticket sales for Korro Bio's second financing round landed at $116 million as the biotech builds up funds to bankroll its RNA editing ...
06.12.2021 · Lessons from evolution: from innate immunity to novel cancer immunotherapies. In recent years, we’ve seen remarkable progress in combatting devastating cancers, with the rise of immunotherapies ...